Press "Enter" to skip to content

New patent for Clarus drug JATENZO

0
Copyright © DrugPatentWatch. Originally published at New patent for Clarus drug JATENZO

Annual Drug Patent Expirations for JATENZO
Annual Drug Patent Expirations for JATENZO

Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

Drug patent litigation for JATENZO.

This drug has twenty-four patent family members in nine countries.

The generic ingredient in JATENZO is testosterone undecanoate. One supplier is listed for this compound. Additional details are available on the testosterone undecanoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Clarus drug JATENZO
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions